Objective: To evaluate the efficacy and safety of tigilanol tiglate (TT) for local intratumoral treatment of mast cell tumors (MCTs) in dogs.
Methods: A randomized controlled clinical study in 2 phases involving 123 dogs with cytologically diagnosed MCT. Phase 1 compared 81 TT-treated dogs with 42 control dogs; phase 2 allowed TT treatment of control dogs and retreatment of dogs that failed to achieve tumor resolution after TT treatment in phase 1.
Purpose: Veterinary medicine and human health are inextricably intertwined. Effective tracking of veterinary information - veterinary informatics - impacts not only veterinary medicine, but also public health, informatics research, and clinical care. However, veterinary informatics has received little attention from the general biomedical informatics community.
View Article and Find Full Text PDF